177 related articles for article (PubMed ID: 25545021)
1. Functional role of the KCa3.1 potassium channel in synovial fibroblasts from rheumatoid arthritis patients.
Friebel K; Schönherr R; Kinne RW; Kunisch E
J Cell Physiol; 2015 Jul; 230(7):1677-88. PubMed ID: 25545021
[TBL] [Abstract][Full Text] [Related]
2. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
3. Targeted inhibition of KCa3.1 channel attenuates airway inflammation and remodeling in allergic asthma.
Yu ZH; Xu JR; Wang YX; Xu GN; Xu ZP; Yang K; Wu DZ; Cui YY; Chen HZ
Am J Respir Cell Mol Biol; 2013 Jun; 48(6):685-93. PubMed ID: 23492185
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of KCa3.1 suppresses TGF-β1 induced MCP-1 expression in human proximal tubular cells through Smad3, p38 and ERK1/2 signaling pathways.
Huang C; Day ML; Poronnik P; Pollock CA; Chen XM
Int J Biochem Cell Biol; 2014 Feb; 47():1-10. PubMed ID: 24291552
[TBL] [Abstract][Full Text] [Related]
5. miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma.
Chen Y; Kuang D; Zhao X; Chen D; Wang X; Yang Q; Wan J; Zhu Y; Wang Y; Zhang S; Wang Y; Tang Q; Masuzawa M; Wang G; Duan Y
Oncotarget; 2016 Sep; 7(36):58148-58161. PubMed ID: 27531900
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of candesartan on KCa3.1 potassium channel expression and cell culture and proliferation in peripheral blood CD4
Li H; Zhao JL; Zhang YM; Han SX
Clin Exp Hypertens; 2018; 40(4):303-311. PubMed ID: 29388859
[TBL] [Abstract][Full Text] [Related]
7. The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis.
Xie H; Lu J; Zhu Y; Meng X; Wang R
Toxicol Lett; 2018 Oct; 295():408-415. PubMed ID: 30036685
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the Ca²⁺-dependent K⁺ channel, KCNN4/KCa3.1, improves tissue protection and locomotor recovery after spinal cord injury.
Bouhy D; Ghasemlou N; Lively S; Redensek A; Rathore KI; Schlichter LC; David S
J Neurosci; 2011 Nov; 31(45):16298-308. PubMed ID: 22072681
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression.
Cho ML; Min SY; Chang SH; Kim KW; Heo SB; Lee SH; Park SH; Cho CS; Kim HY
Immunol Lett; 2006 Jun; 105(2):159-66. PubMed ID: 16564576
[TBL] [Abstract][Full Text] [Related]
10. Protease-activated receptor 2, rather than protease-activated receptor 1, contributes to the aggressive properties of synovial fibroblasts in rheumatoid arthritis.
Xue M; Chan YK; Shen K; Dervish S; March L; Sambrook PN; Jackson CJ
Arthritis Rheum; 2012 Jan; 64(1):88-98. PubMed ID: 21905006
[TBL] [Abstract][Full Text] [Related]
11. Different expression of β subunits of the KCa1.1 channel by invasive and non-invasive human fibroblast-like synoviocytes.
Pethő Z; Tanner MR; Tajhya RB; Huq R; Laragione T; Panyi G; Gulko PS; Beeton C
Arthritis Res Ther; 2016 May; 18(1):103. PubMed ID: 27165430
[TBL] [Abstract][Full Text] [Related]
12. K
Bonito B; Sauter DR; Schwab A; Djamgoz MB; Novak I
Pflugers Arch; 2016 Nov; 468(11-12):1865-1875. PubMed ID: 27752766
[TBL] [Abstract][Full Text] [Related]
13. Regulation of neurokinin-1 receptor messenger RNA expression in synovial fibroblasts of patients with rheumatoid arthritis.
Akasaka Y; Abe K; Sato T; Inoue H
Neuropeptides; 2005 Oct; 39(5):467-74. PubMed ID: 16154193
[TBL] [Abstract][Full Text] [Related]
14. Altered K
Seo CH; Cui HS; Kim JB
Transl Res; 2021 Oct; 236():133-146. PubMed ID: 33905948
[TBL] [Abstract][Full Text] [Related]
15. Expression and Functions of Immediate Early Response Gene X-1 (IEX-1) in Rheumatoid Arthritis Synovial Fibroblasts.
Morinobu A; Tanaka S; Nishimura K; Takahashi S; Kageyama G; Miura Y; Kurosaka M; Saegusa J; Kumagai S
PLoS One; 2016; 11(10):e0164350. PubMed ID: 27736946
[TBL] [Abstract][Full Text] [Related]
16. Calcium-dependent potassium channels control proliferation of cardiac progenitor cells and bone marrow-derived mesenchymal stem cells.
Vigneault P; Naud P; Qi X; Xiao J; Villeneuve L; Davis DR; Nattel S
J Physiol; 2018 Jun; 596(12):2359-2379. PubMed ID: 29574723
[TBL] [Abstract][Full Text] [Related]
17. Blockade of the intermediate-conductance Ca(2+)-activated K+ channel inhibits the angiogenesis induced by epidermal growth factor in the treatment of corneal alkali burn.
Yang H; Li X; Ma J; Lv X; Zhao S; Lang W; Zhang Y
Exp Eye Res; 2013 May; 110():76-87. PubMed ID: 23482085
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of vascular calcification by block of intermediate conductance calcium-activated potassium channels with TRAM-34.
Freise C; Querfeld U
Pharmacol Res; 2014 Jul; 85():6-14. PubMed ID: 24813858
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis.
Ospelt C; Brentano F; Rengel Y; Stanczyk J; Kolling C; Tak PP; Gay RE; Gay S; Kyburz D
Arthritis Rheum; 2008 Dec; 58(12):3684-92. PubMed ID: 19035519
[TBL] [Abstract][Full Text] [Related]
20. Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation.
Xue M; McKelvey K; Shen K; Minhas N; March L; Park SY; Jackson CJ
Rheumatology (Oxford); 2014 Dec; 53(12):2270-9. PubMed ID: 24982240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
